ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 90 filers reported holding ATHIRA PHARMA INC in Q2 2021. The put-call ratio across all filers is 2.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $39,000 | 0.0% | 13,008 | +0.7% | 0.02% | +14.3% |
| Q2 2022 | $39,000 | -75.0% | 12,914 | +11.7% | 0.01% | -80.0% |
| Q1 2022 | $156,000 | -2.5% | 11,561 | -5.6% | 0.07% | +16.7% |
| Q4 2021 | $160,000 | +55.3% | 12,249 | +11.8% | 0.06% | +33.3% |
| Q3 2021 | $103,000 | -12.7% | 10,956 | -5.0% | 0.04% | -8.2% |
| Q2 2021 | $118,000 | – | 11,530 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $57,938,000 | 8.52% |
| ACUTA CAPITAL PARTNERS, LLC | 393,000 | $13,460,000 | 3.66% |
| Logos Global Management LP | 947,873 | $32,465,000 | 2.78% |
| RTW INVESTMENTS, LP | 2,685,779 | $88,899,000 | 1.49% |
| Avidity Partners Management LP | 1,043,873 | $35,753,000 | 1.16% |
| Perceptive Advisors | 3,114,805 | $106,682,000 | 1.14% |
| Sofinnova Investments, Inc. | 509,168 | $17,439,000 | 1.04% |
| HighVista Strategies LLC | 32,062 | $1,098,000 | 0.70% |
| Rock Springs Capital Management LP | 860,902 | $29,486,000 | 0.62% |
| PFM Health Sciences, LP | 470,227 | $16,105,000 | 0.57% |